Dr Dave S Atteberry, MD - Medicare Neurosurgery in Yakima, WA

Dr Dave S Atteberry, MD is a medicare enrolled "Neurological Surgery" physician in Yakima, Washington. He went to University Of Pittsburgh School Of Medicine and graduated in 2001 and has 23 years of diverse experience with area of expertise as Neurosurgery. He is a member of the group practice Direct Imaging Pc, Shc Medical Center Toppenish, Sunnyside Community Hospital Association and his current practice location is 6101 Summitview Ave Ste 200, Yakima, Washington. You can reach out to his office (for appointments etc.) via phone at (509) 902-8857.

Dr Dave S Atteberry is licensed to practice in Washington (license number MD60125290) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1427252147.

Contact Information

Dr Dave S Atteberry, MD
6101 Summitview Ave Ste 200,
Yakima, WA 98908-3028
(509) 902-8857
(509) 902-8855



Physician's Profile

Full NameDr Dave S Atteberry
GenderMale
SpecialityNeurosurgery
Experience23 Years
Location6101 Summitview Ave Ste 200, Yakima, Washington
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Dave S Atteberry attended and graduated from University Of Pittsburgh School Of Medicine in 2001
  NPI Data:
  • NPI Number: 1427252147
  • Provider Enumeration Date: 06/14/2007
  • Last Update Date: 12/18/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4880763663
  • Enrollment ID: I20100121000798

Medical Identifiers

Medical identifiers for Dr Dave S Atteberry such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1427252147NPI-NPPES
426319OtherWAEMPLOYER CLINIC L&I GR. NO.: DIRECT IMAGING, PC
1326340969MedicaidWA
1689283285OtherEMPLOYER NPI: DIRECT IMAGING, PC
0271934OtherWAL & I
G9016479OtherEMPLOYER PTAN: DIRECT IMAGING, PC
426432OtherWAEMPLOYER RADIOLOGY L&I GR. NO.: DIRECT IMAGING, PC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207T00000XNeurological Surgery MD422565 (Pennsylvania)Secondary
207T00000XNeurological Surgery MD60125290 (Washington)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Astria Sunnyside HospitalSunnyside, WAHospital
Klickitat Valley HospitalGoldendale, WAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Direct Imaging Pc61032449344
Shc Medical Center Toppenish408298006531
Sunnyside Community Hospital Association165828089643

News Archive

Humana sees strong future in Medicare; AHIP seeks more cost containment measures

The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Dave S Atteberry allows following entities to bill medicare on his behalf.
Entity NameSunnyside Community Hospital Association
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609395060
PECOS PAC ID: 1658280896
Enrollment ID: O20040227000194

News Archive

Humana sees strong future in Medicare; AHIP seeks more cost containment measures

The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

Read more Medical News

› Verified 3 days ago

Entity NameShc Medical Center Toppenish
Entity TypePart B Supplier - Hospital Department(s)
Entity IdentifiersNPI Number: 1851817308
PECOS PAC ID: 4082980065
Enrollment ID: O20171018001921

News Archive

Humana sees strong future in Medicare; AHIP seeks more cost containment measures

The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

Read more Medical News

› Verified 3 days ago

Entity NameDirect Imaging Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689283285
PECOS PAC ID: 6103244934
Enrollment ID: O20200910002932

News Archive

Humana sees strong future in Medicare; AHIP seeks more cost containment measures

The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

Read more Medical News

› Verified 3 days ago

Entity NameDirect Imaging Pc
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1689283285
PECOS PAC ID: 6103244934
Enrollment ID: O20210415000829

News Archive

Humana sees strong future in Medicare; AHIP seeks more cost containment measures

The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Dave S Atteberry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Dave S Atteberry, MD
6101 Summitview Ave Ste 200,
Yakima, WA 98908-3028

Ph: (509) 902-8857
Dr Dave S Atteberry, MD
6101 Summitview Ave Ste 200,
Yakima, WA 98908-3028

Ph: (509) 902-8857

News Archive

Humana sees strong future in Medicare; AHIP seeks more cost containment measures

The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

ALS TDI forms research partnership with Neurimmune to advance potential treatments for ALS

The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments for ALS, also known as Lou Gehrig's disease.

Solana's CrossCHECK Plating System receives FDA clearance

Solana Surgical, LLC, a growth extremity company, announces the FDA Clearance of the CrossCHECK™ Plating System, a new implant system for orthopedic and podiatric surgeons' use in foot and ankle procedures. Commercialization will follow in the first quarter of 2014.

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

Read more News

› Verified 3 days ago


Neurological Surgery Doctors in Yakima, WA

Dr. Eduardo Meirelles, M.D., PH.D
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 1110 N. 35th Ave, Yakima, WA 98902
Phone: 509-834-7050    Fax: 509-834-7051
Leslie R Bornfleth, MD
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 111 S 11th Ave, Suite 321, Yakima, WA 98902
Phone: 509-248-3954    Fax: 509-248-3955
Voderbet C Kamath, MD
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 307 S 12th Ave, Ste 19, Yakima, WA 98902
Phone: 509-469-1446    Fax: 509-469-1905

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.